Press releases
- Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A
- Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
- Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
- Sobi publishes Annual and sustainability report for 2023
- Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
More ▼
Key statistics
On Wednesday, Swedish Orphan Biovitrum AB (publ) (SWOBY:PKL) closed at 13.48, -18.33% below its 52-week high of 16.50, set on Oct 04, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 13.48 |
---|---|
High | 13.48 |
Low | 13.48 |
Bid | -- |
Offer | -- |
Previous close | 13.48 |
Average volume | 277.67 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of May 01 2024 16:57 BST.
More ▼